Moderna’s COVID-Flu combo shot beats separate vaccines in phase III study
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Alumis readies IPO to fund rival drug to Bristol Myers’ Sotyktu
Boehringer, Lilly face off in MASH at EASL
*please scroll down for all the latest news*
